Biochip Market Analysis by Application and Trend 2017-2021
Biochip technology has been widely used in genetic engineering and analysis. These chips have DNA strands attached to the surface, and can detect samples with extremely small concentration. Genetic biochips or genechips have accelerated genome sequencing and are now being incorporated in devices for easy and rapid analysis. Scientists have developed biochip transponder which is placed under the skin to provide unique identification. Integration of biochip technology with genetic and protein research has facilitated rapid and accurate analysis. Application of microarray and microfluidic technology in veterinary diagnosis has increased considerably in the recent past. Biochips in animal health are used in disease diagnosis and genotyping.
Request Free Report Sample@ http://www.sa-brc.com/Global-Biochip-Market-Assessment--Forecast-2017-2021/up78
Increasing understanding of biomarkers and genetic makeup and their role in disease diagnosis and progression is expected to increase application of biochips in routine diagnosis. Majority of the overall biochips market is dominated by North America, Europe and Asia Pacific geographies. It is expected that more number of biotechnology research institutes would emerge in the near future owing to increased government funding and acknowledgement of success in biopharmaceutical research through regulatory approvals and new policy amendments.
From the clinical point-of-view, there is huge demand for rapid diagnosis and targeted therapy. Economic burden for diseases such as cancer, diabetes, cardiovascular and neurological diseases is increasing rapidly across the globe. National Cancer Institute, U.S. estimates over 1.68 million new cancer cases diagnosed in the U.S. in 2016. In U.K. 0.35 million new cancer cases were recorded as per Cancer Research U.K, while globally more than 8 million patients die due to cancer. According to World Health Organization (WHO) over 422 million individuals were recorded having diabetes in 2014 globally. Research also estimates that the prevalence of these chronic diseases is expected to rise in the coming years, which would provide necessary leverage for the biochip market growth.
Request For TOC@ http://www.sa-brc.com/Global-Biochip-Market-Assessment--Forecast-2017-2021/upcomingdetail78
ProtoArray human protein microarray by Thermo Fisher Scientific consists of over 9,000 unique human proteins and enables biomarker identification with concentration as low as 10 ?L. These systems also help in mapping protein-protein interaction for providing more insights to complex biochemical pathways. Other key players in the global biochip market are Agilent Technologies, Inc., Bio-Rad laboratories, Inc., PerkinElmer Inc., Randox Laboratories, Illumina, Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore, VHLGenetics, Median Diagnostic, Inc. and others.
NOTE: This report is currently under research and will be made available to clients on request.
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.
Office No. 14,
Hermes Kunj, Mangaldas Road,
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biochip Market Analysis by Application and Trend 2017-2021 here
News-ID: 642107 • Views: 292
More Releases from SA-BRC
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The
Global Antidiabetic Drugs Market - Product Segment Analysis And Forecast
Diabetes is a major lifestyle disorder affecting millions of individuals globally. The disorder is also linked with other complications such as diabetic retinopathy, diabetic foot ulcers, nephropathy and cardiovascular complications among others. Wide spread global prevalence and rising incidence rate has made the antidiabetic drugs market attractive for pharmaceutical drug manufacturers. Introduction of superior products in the recent past and increasing patient compliance are other factors driving the diabetes treatment
More Releases for Biochip
Biochip Market Trends & Outlook 2019 | Danaher Corp., Illumina, Inc., Qiagen N.V …
The biochips market growth outlook is positive with significant growth potential for DNA microarray. There is pressure on biochip manufacturers to reduce prices of biochips from medical diagnostic companies and research organizations as biochip prices are limiting the growth of the market. At the same time, increasing use of biochips in pharmaceutical research and development activities, concerns regarding animal testing, rising use of DNA microarrays for cancer diagnosis is contributing
Biochip Market To Achieve Significant Gains and Forecast Between 2018 to 2025
Qyresearchreports include new market research report “Global Biochip Market Professional Survey Report 2018” to its huge collection of research reports. In molecular biology, biochips are essentially miniaturized laboratories that can perform hundreds or thousands of simultaneous biochemical reactions. Biochips enable researchers to quickly screen large numbers of biological analytes for a variety of purposes, from disease diagnosis to detection of bioterrorism agents. Digital microfluidic biochips have become one of the most
Biochip Products Market Research Analysis By Experts 2018 To 2025
Qyresearchreports include new market research report “Global Biochip Products Sales Market Report 2018” to its huge collection of research reports. Global Biochip Products market competition by top manufacturers/players, with Biochip Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Illumina Thermo Fisher Scientific Cellix GE Healthcare Randox BioDot PerkinElmer Roche Horiba Download Free exclusive Sample of this report: https://www.qyresearchreports.com/sample/sample.php?rep_id=1507482&type=S As every market is characterized by a unique set of competition between key players,
Global Biochip Market Professional Survey Report 2017
Researchmoz added Most up-to-date research on "Global Biochip Market Professional Survey Report 2017" to its huge collection of research reports. This report studies Biochip in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share
Biochip Market 2017 Trend, Analysis and Forecast to 2021
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the
Biochip Market Growth with Worldwide Industry Analysis to 2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has